$VANI Income Statement | Understand Stock

$VANI

$1.13 +$0.02 (1.8%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net sales
Cost of sales
Gross profit
Operating expenses:
Research and development, net of grants
Clinical and regulatory, net of grants
General and administrative, net of grants
Total operating expenses

Loss from operations
Other income
Gain on bargain purchase
Other income (expense), net
Other income, net
Net loss
Net loss per common share – basic and diluted
Weighted average shares outstanding – basic and diluted
Net loss per common share - basic and diluted
Weighted average shares outstanding - basic and diluted
Net loss per common share - basic (in dollars per share)
Net loss per common share - diluted (in dollars per share)
Weighted average shares outstanding - basic (in shares)
Weighted average shares outstanding - diluted (in shares)

Comments